Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.234 EUR | +1.15% |
|
+13.07% | +78.58% |
05-31 | Hansa Biopharma Finalizes Patient Randomization for Use of Imlifidase inKidney Transplantation Trial | MT |
05-31 | Hansa Biopharma Completes Randomization in Pivotal Phase 3 Us Confides Trial | CI |